 MELBOURNE, Australia, Nov. 17, 2020 GLOBE NEWSWIRE -- Molecular diagnostics company Genetic Technologies Limited ASX: GTG; Nasdaq: GENE, Company is pleased to announce its interim-CEO, Dr. Jerzy Muchnicki, will share insight into the companys recent developments during an investor webinar on Thursday, November 19, 2020 at 4:15 p.m. ET. A live QA session with Dr. Muchnicki will follow the presentation. 